These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17191173)

  • 1. Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection.
    Polley SD; Tetteh KK; Lloyd JM; Akpogheneta OJ; Greenwood BM; Bojang KA; Conway DJ
    J Infect Dis; 2007 Jan; 195(2):279-87. PubMed ID: 17191173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.
    Bang G; Prieur E; Roussilhon C; Druilhe P
    PLoS One; 2011; 6(12):e28165. PubMed ID: 22145028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
    Tonhosolo R; Wunderlich G; Ferreira MU
    J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.
    Osier FH; Polley SD; Mwangi T; Lowe B; Conway DJ; Marsh K
    Parasite Immunol; 2007 Aug; 29(8):387-94. PubMed ID: 17650180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3.
    Roussilhon C; Oeuvray C; Müller-Graf C; Tall A; Rogier C; Trape JF; Theisen M; Balde A; Pérignon JL; Druilhe P
    PLoS Med; 2007 Nov; 4(11):e320. PubMed ID: 18001147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
    de Silva HD; Saleh S; Kovacevic S; Wang L; Black CG; Plebanski M; Coppel RL
    Malar J; 2011 Sep; 10():266. PubMed ID: 21920045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malaria.
    Metzger WG; Okenu DM; Cavanagh DR; Robinson JV; Bojang KA; Weiss HA; McBride JS; Greenwood BM; Conway DJ
    Parasite Immunol; 2003 Jun; 25(6):307-12. PubMed ID: 14507328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria.
    Osier FH; Murungi LM; Fegan G; Tuju J; Tetteh KK; Bull PC; Conway DJ; Marsh K
    Parasite Immunol; 2010 Mar; 32(3):193-201. PubMed ID: 20398182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
    Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
    Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.
    Terheggen U; Drew DR; Hodder AN; Cross NJ; Mugyenyi CK; Barry AE; Anders RF; Dutta S; Osier FH; Elliott SR; Senn N; Stanisic DI; Marsh K; Siba PM; Mueller I; Richards JS; Beeson JG
    BMC Med; 2014 Oct; 12():183. PubMed ID: 25319190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum merozoite surface antigen-specific cytophilic IgG and control of malaria infection in a Beninese birth cohort.
    Adamou R; Dechavanne C; Sadissou I; d'Almeida T; Bouraima A; Sonon P; Amoussa R; Cottrell G; Le Port A; Theisen M; Remarque EJ; Longacre S; Moutairou K; Massougbodji A; Luty AJF; Nuel G; Migot-Nabias F; Sanni A; Garcia A; Milet J; Courtin D
    Malar J; 2019 Jun; 18(1):194. PubMed ID: 31185998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
    Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
    Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity.
    Tetteh KK; Osier FH; Salanti A; Kamuyu G; Drought L; Failly M; Martin C; Marsh K; Conway DJ
    Infect Immun; 2013 Oct; 81(10):3835-42. PubMed ID: 23897617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat sequences in block 2 of Plasmodium falciparum merozoite surface protein 1 are targets of antibodies associated with protection from malaria.
    Polley SD; Tetteh KK; Cavanagh DR; Pearce RJ; Lloyd JM; Bojang KA; Okenu DM; Greenwood BM; McBride JS; Conway DJ
    Infect Immun; 2003 Apr; 71(4):1833-42. PubMed ID: 12654798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2.
    Hoffmann EH; da Silveira LA; Tonhosolo R; Pereira FJ; Ribeiro WL; Tonon AP; Kawamoto F; Ferreira MU
    Ann Trop Med Parasitol; 2001 Mar; 95(2):117-32. PubMed ID: 11299119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen.
    Pearce JA; Triglia T; Hodder AN; Jackson DC; Cowman AF; Anders RF
    Infect Immun; 2004 Apr; 72(4):2321-8. PubMed ID: 15039357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.